In order to determine whether known familial PD mutations were associated with the rate of disease progression, we performed genetic screening on the SNCA, PARK2 and LRRK2 genes, known to cause a substantial fraction of monogenic PD cases [27]. This evidence concerns the gene PRKN and Parkinson disease.